Physician profile
Jaime Strachan
NPI 1013953777
$27,507.32
in general payments reported to CMS, 2019-2025
32 companies · $6,415 in 2025
The $6,415 reported for 2025 was more than what 87% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,739 · 2020: $449 · 2021: $584 · 2022: $2,882 · 2023: $7,334 · 2024: $8,104 · 2025: $6,415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $17K · Food and Beverage: $5,020.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $16,833.33 |
| Food and Beverage | $5,019.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $18,290.23 | 2022-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Boston Scientific Corporation | $2,277.25 | 2019-2025 | Eluvia, Opticross 35, Ekosonic |
| Medtronic, INC. | $1,523.07 | 2021-2025 | Endurant Iis, Abre, Ellipsys Vascular Access System |
| Bard Peripheral Vascular, INC. | $1,424.42 | 2019-2025 | Crosser Iq, Lutonix Drug Coated Balloon, Crosser Iq |
| Inari Medical, INC. | $864.27 | 2019-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Endologix LLC | $739.98 | 2019-2024 | Alto Abdominal Stent Graft System |
| Avinger INC. | $349.38 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $263.20 | 2019-2025 | Eliquis |
| Stryker Corporation | $262.74 | 2025 | Artix Mt, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic Vascular, INC. | $194.09 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $185.65 | 2019-2024 | Xarelto |
| Silk Road Medical, INC. | $163.84 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Philips North America LLC | $150.09 | 2019-2022 | |
| Smith+Nephew, INC. | $97.46 | 2019-2020 | |
| Lemaitre Vascular, INC. | $94.96 | 2019-2024 | Trivex System, Artegraft Vascular Graft |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocompatibles, INC. | $76.32 | 2019 | |
| Solventum Corporation | $72.15 | 2025 | Prevena, V.A.C.Ulta, Activ.A.C. |
| Tactile Systems Technology INC | $66.30 | 2021-2024 | Flexitouch Plus, Entre Plus |
| Pfizer INC. | $50.40 | 2019-2023 | |
| Cook Medical LLC | $49.04 | 2021-2025 | Zenith Alpha, Advance |
| Cardiva Medical, INC. | $46.86 | 2023-2024 | Cardiva Vascade 6/7f Vcs |
| Abbott Laboratories | $45.99 | 2022-2023 | Jeti Peripheral Catheter |
| Cardiovascular Systems INC. | $39.67 | 2019-2021 | |
| Biotronik INC. | $32.89 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.22 | 2023 | Gattex |
| Laminate Medical Technologies INC. | $21.50 | 2025 | Vasq |
| Covidien LP | $20.58 | 2019 | |
| Cagent Vascular INC | $19.32 | 2024 | Serrantor |
| Paratek Pharmaceuticals, INC. | $18.11 | 2023 | Nuzyra |
| Reprise Biomedical, INC. | $17.58 | 2023 | Miro3d |
| Cordis US Corp. | $14.19 | 2024 | Mynx Control |
| W. L. Gore & Associates, INC. | $12.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaime Strachan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.